FCgamma Receptor Polymorphisms Do Not Influence the Outcome of Treatment with Rituximab Followed by Active Immunotherapy with Mitumprotimut-T (FavId®, Id-KLH).
Year: 2007
Type: article
Source: Blood
Authors: David G. Maloney, Barbara Pender, Erin McCarthy, Daniel P. Gold
Institution: Fred Hutch Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2567184590
